Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Sharon Osbourne sparked surgery concern once again this week as she stepped out in LA on Wednesday with a noticeably more ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

SGLT2 diabetes meds like Jardiance or Farxiga do the same, and also decrease risk of a follow-up stroke MONDAY, Nov. 11, 2024 ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...